
Transitioning From Acute to Chronic Care in PAD: From Latest Evidence to Clinical Care
Target Audience
Learning Objectives
- Have increased knowledge regarding the
- Emerging data on the role of factor Xa inhibitors in the treatment of patients with peripheral artery disease who are undergoing a revascularization
- Have greater competence related to
- The use of appropriate antithrombotic strategies for patients post-limb revascularization to prevent limb loss
- 0.50 AMA PRA Category 1 Credit™
- 0.50 Participation
FACULTY
Professor of Medicine
Director of Vascular Medicine
Vanderbilt University Medical Center
Nashville, Tennessee
Professor
Chief of the Division of Vascular and Endovascular Surgery
Edwin J. Wylie, MD Chair, Vascular Surgery
University of California, San Francisco
Associate Professor of Medicine
Director of Vascular Research
University of Colorado School of Medicine
Executive Director; CPC Clinical Research
Aurora, Colorado
President, Colorado Prevention Center (CPC)
Professor, Medicine-Cardiology
University of Colorado Hospital (UCH)
Aurora, Colorado
COURSE REVIEWER
Vice Chair for Clinical Operations
Department of Medicine
Section of Cardiology
University of Chicago Medicine
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Developed through a collaboration between the University of Chicago Medicine and Medscape Education.
Other Healthcare Professions Credit
Click here to view the activity or if you are logged in click on the "Complete Activity" button!